Novartis Investigative Site

Delhii 110 085

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer — Completed